Clinical Trial: A Study in Pediatric Participants With Generalized Anxiety Disorder

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional




Official Title: A Double-Blind, Efficacy and Safety Study of Duloxetine Versus Placebo in the Treatment of Children and Adolescents With Generalized Anxiety Disorder

Brief Summary: The purpose of this study is to find out if duloxetine [30-120 milligrams (mg)] given once a day by mouth for 10 weeks to children and adolescents, is better than placebo when treating Generalized Anxiety Disorder (GAD).